联合吸入皮质类固醇和短效β2激动剂 (ICS-SABA) 用于患有喘的老年人
Jaycie Truong1, Kimberly A B Cauthon2
11 University of Texas Medical Branch-Correctional Managed Care, Huntsville, Texas.
The Senior care pharmacist
|January 3, 2025
概括
新的吸入性皮质类固醇和短效β2激动剂 (ICS-SABA) 吸入器为老年人提供了一种更安全的喘管理方法. 研究表明,ICS-SABA可以减少严重的喘发作,并改善肺功能,副作用最小.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 老年医学 老年医学
背景情况:
- 美国食品和药物管理局于2023年批准了第一个吸入性皮质类固醇和短效β2激动剂 (ICS-SABA) 组合,用于根据需要治疗喘.
- 目前的GINA指南建议根据需要使用ICS-formoterol或ICS与任何SABA使用.
- 关于老年人使用ICS-SABA的研究有限,尽管GINA指南中没有针对年龄的治疗差异.
研究的目的:
- 对DENALI和MANDALA研究进行审查.
- 评估ICS-SABA缓解吸入器在患有喘的老年人中的潜在作用.
主要方法:
- 对DENALI和MANDALA临床试验的分析,其中包括平均年龄为50岁的参与者.
- 在MANDALA试验中对老年人的子组分析.
- 对减少喘恶化和改善肺功能 (FEV1) 的疗效评估.
主要成果:
- 曼达拉试验显示,与ICS-SABA相比,ICS-SABA对严重恶化症的统计显著减少,与按需使用的阿尔布特罗尔相比.
- 在曼达拉的老年人亚组中,结果偏好了ICS-SABA而不是单独使用阿尔布特罗尔,尽管这在统计学上并不显著.
- 在DENALI试验中,与单独使用布德索尼德或安慰剂相比,使用阿尔布特罗尔/布德索尼德组合的肺功能 (FEV1) 得到改善.
结论:
- ICS-SABA吸入器在预防喘恶化和改善肺功能方面显示出好处.
- 在DENALI和MANDALA试验中观察到最小的不良影响.
- 患有喘的老年人应评估并建议使用ICS-SABA缓解吸入器.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
117
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
117
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
131
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
131
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
146
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
146
01:30Asthma-IV: Diagnostic and Management
2.4K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.4K
01:23Inhaled Medications
195
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
195
01:17Drugs Used in Lower Respiratory Disorders: Overview
241
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
241